Popovici, A. , Geschiekter, C.F., Reinev-Sky , A., AND Rubin, M.: Experimental control of serum calcium levels in vivo. Proc. Soc. Exper. Biol. &Med., 74: 415, 1950.
2.
Rostenberg, A., JR., AND Perkins , A.J.: Nickel and cobalt dermatitis. J. Allergy,22: 466, 1951.
3.
Proescher, F. : Anticoagulant properties of ethylenediamine tetra-acetic acid. Proc. Soc. Exper. Biol. &Med., 76: 619, 1951.
4.
Gehres, R.F. , AND Raymond, S.: A new chemical approach to the solution of urinary calculi. J. Urol., 65: 464, 1951.
5.
Belknap, E.L. : EDTA in the treatment of lead poisoning. Indust . Med., 21: 305, 1952.
6.
Grant, W.M.: New treatment of corneal opacities. A. M. A. Arch. Ophth.,48: 681, 1952.
7.
Spencer, H., Vankinscott, V., Lewin, I., AND Laszlo, D.: Removal of calcium in man by ethylenediamide tetra-acetic acid: metabolic study. J. Clin. Invest., 31: 1023, 1952.
8.
Marcos DELa Mano, J.L.: Estudios sobre la disolucion de calculos urinarios. Rev. clin. Españ.,48: 247, 1953.
9.
Wishinsky, H. , Weinberg, T., Prevost , E.M., Burgin, F., AND Miller, M.J.: Ethylenediaminetetracetic acid in the mobilization and removal of iron in a case of hemochromatosis . J. Lab. & Clin. Med., 42: 550, 1953.
10.
Holland, J.F. , Danielson, E., AND Saha-Gian-Edwards , A.: Use of ethylene diamide tetracetic acid in hypercalcemic patients. Proc. Soc. Exper. Biol. &Med., 84: 359, 1953.
11.
Vaughan, J. , AND Tutt, M.: Use of ethylenediamine tetra-acetic acid (Versene) for removing fission products from the skeleton. Lancet, 2: 856, 1953.
12.
Kurtin, A., AND Orentreich, N.: Chelation deactivation of nickel ion in allergic eczematous sensitivity . J. Invest. Dermat., 22: 441, 1954.
13.
Maloof, C.C. : Use of edathamil calcium in treatment of chrome ulcers of the skin. A. M. A. Arch. Indust. Hyg.,11: 123, 1955.
14.
Clarke, N.E. , Clarke, C.N., AND Mosher, R.D.: The in vivo dissolution of metastatic calcium: an approach to atherosclerosis. Am. J. M. Sc.,229: 142, 1955.
15.
Perry, H.M. , JR., AND Schroeder , H.A.: Depression of cholesterol levels in human plasma following ethylene diamine tetra-acetate and hydrolazine . J. Chronic Dis.,2: 520, 1955.
16.
Klein, R., AND Harris, S.B.: Treatment of scleroderma, sclerodactylia and calcinosis by chelation (EDTA) . Am. J. Med., 19: 798, 1955.
17.
Clarke, N.E. , Clarke, C.N., AND Mosher, R.E.: Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am. J. M. Sc.,232: 654, 1956.
18.
Bechtel, J.T. , White, J.E., AND Estes, H.D.: Electrocardiographic effects of hypocalcemia induced in normal subjects with edathamil disodium . Circulation , 13: 837, 1956.
19.
Gubner, R.S. , AND Kallman, H.: Treatment of digitalis toxicity by chelation of serum calcium. Am. J. M. Sc.,234: 136, 1957 .
20.
Perry, H.M. , JR., AND Schroeder , H.A.: Lesions resembling vitamin B complex deficiency and urinary loss of zinc produced by EDTA. Am. J. Med., 22: 168, 1957.
21.
Weinberg, E.D. : Mutual effects of antimicrobial compounds and metallic cations. Bact. Rev., 21: 46, 1957.
22.
Rukavina, J.G. , Mendelson, C., Price , J.M., Brown, R.R., AND Johnson, S.A.M.: Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by chelation (EDTA). J. Invest. Dermat., 29: 273-288, 1957.
23.
Rukavina, J.G. , Orkin, M., AND Lynch, F.W.: The Effect of an Intravenous Chelating Agent, Edathamil Disodium (Na2-EDTA), in 3 Cases of Sarcoidosis . J. Invest. Dermat., 31: 259, 1958.
24.
Berryman, G.H. : Chelation, trace metals and disease. What's New, Numbers 205 and 206, 1958.
25.
Muller, S.A. , Brunsting, L.A., AND Win-Kelmann , R.K.: The treatment of scleroderma with the new chelating agent, edathamil. A. M. A. Arch. Dermat.,80: 187, 1959.
26.
Clarke, N.E. , SR., Clarke, N.E., JR., AND Mosher , R.E.: Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA). Am. J. M. Sc., 239: 732, 1960.
27.
Clarke, Norman E., SR.: Atherosclerosis, occlusive vascular disease and EDTA. Am. J. Cardiol., 6: 233, 1960.
Kitchell, J.R. , Meltzer, L.E., AND Seven, M.J.: Potential uses of chelation methods in the treatment of cardiovascular diseases. Progr. Cardiovas. Dis.,3: 338, 1961.
30.
Bolick, L.E. , AND Blankenhorn, D.H. : A quantitative study of coronary arterial calcification . Am. J. Path., 39: 511, 1961.
31.
Dudley, H.R. , Ritchie, A.C., Schilling, A., AND Baker, W.H.: Pathological changes associated with the use of ethylene diamine tetra-acetate in the treatment of hypercalcemia. New England J. Med., 252: 331, 1955.
32.
Meltzer, L.E. , Kitchell, J.R., AND Palmon, F., JR.: The long term use, side-effects, and toxicity of disodium ethylenediamide tetraacetic acid (EDTA). Am. J. M. Sc., 24: 51, 1961.
33.
Lamar, C.P. : Comparative oral glucose and oral fructose tolerance tests in normal subjects and in diabetic patients. J. Florida M. A.,46: 180, 1959.